RE

RESEARCH MEDICAL INC

  • CIK: 0000083306
  • EIN: 87-0277827
  • Business address: 6864 S 300 W, MIDVALE, Utah, 84047

Information

  • Mailing address
    6864 S 300 WEST, MIDVALE, Utah, 84047
  • Phone
    8015620200
  • State location
    Utah
  • State of incorporation
    Utah
  • Fiscal year end
    June 30
  • SIC
    3841 - (CF Office: Office of Life Sciences) SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
  • Filings
    N/A

About RESEARCH MEDICAL INC

RESEARCH MEDICAL INC (CIK: 0000083306) is an American company incorporated in the state of Utah. Head office is located at 6864 S 300 W, MIDVALE, Utah, 84047. Work in the industry 3841 - (CF Office: Office of Life Sciences) SURGICAL & MEDICAL INSTRUMENTS & APPARATUS. RESEARCH MEDICAL INC is a public company and trade via Over-The-Counter (OTC).

Old names:

  • RESEARCH INDUSTRIES CORP from 1995-27-Sep to 1996-14-Feb

Ownership

Updating!

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by RESEARCH MEDICAL INC

Filings Format Description Filed/Effective File/Film Number
15-15D Document

Notice of suspension of duty to file reports pursuant to Section 13 and 15(d) of the Act

Acc-no: 0000912057-97-008902 ( Act) Size: 4 KB		 Mar-14-1997

002-99305

97557158
SC 13G Document

Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions

Acc-no: 0000950123-97-001344 ( Act) Size: 19 KB		 Feb-14-1997

005-40357

97533649
10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0000083306-97-000002 ( Act) Size: 30 KB		 Feb-06-1997

000-06944

97519033
SC 13D Document

Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities

Acc-no: 0000905718-97-000009 ( Act) Size: 18 KB		 Jan-14-1997

005-40357

97505570
8-K Document

Current report filing

Acc-no: 0000912057-97-000677 ( Act) Size: 159 KB		 Jan-10-1997

000-06944

97504254
8-K Document

Current report filing

Acc-no: 0000083306-96-000017 ( Act) Size: 11 KB		 Dec-17-1996

000-06944

96682167
10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0000083306-96-000014 ( Act) Size: 28 KB		 Oct-31-1996

000-06944

96651360
DEF 14A Document

Definitive proxy statements

Acc-no: 0000083306-96-000012 ( Act) Size: 29 KB		 Oct-09-1996

000-06944

96640913
10-K Document

Annual report pursuant to section 13 and 15(d)

Acc-no: 0000083306-96-000010 ( Act) Size: 105 KB		 Sep-25-1996

000-06944

96634056
10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0000083306-96-000008 ( Act) Size: 30 KB		 May-15-1996

000-06944

96565475
SC 13G Document

Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions

Acc-no: 0000950123-96-000638 ( Act) Size: 18 KB		 Feb-14-1996

005-40357

96519284
10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0000083306-96-000002 ( Act) Size: 30 KB		 Feb-12-1996

000-06944

96515297
10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0000083306-95-000019 ( Act) Size: 27 KB		 Oct-27-1995

000-06944

95584797
POS AM Document

Post-effective amendment to a registration statement that is not immediately effective upon filing

Acc-no: 0000083306-95-000017 ( Act) Size: 7 KB		 Oct-23-1995

033-59419

95583181
DEF 14A Document

Definitive proxy statements

Acc-no: 0000083306-95-000015 ( Act) Size: 25 KB		 Oct-02-1995

000-06944

95578071
10-K Document

Annual report pursuant to section 13 and 15(d)

Acc-no: 0000083306-95-000013 ( Act) Size: 91 KB		 Sep-27-1995

000-06944

95576318
PRE 14A Document

Preliminary proxy statement not related to a contested matter or merger/acquisition

Acc-no: 0000083306-95-000011 ( Act) Size: 23 KB		 Aug-28-1995

000-06944

95567464
S-3 Document

Registration statement for specified transactions by certain issuers

Acc-no: 0000083306-95-000008 ( Act) Size: 93 KB		 May-18-1995

033-59419

95540688
10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0000083306-95-000004 ( Act) Size: 37 KB		 May-11-1995

000-06944

95536795

Recent 20 filings. View all RESEARCH MEDICAL INC filings

Reviews

Overall rating 5.0

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Frequently Asked Questions

Tags:

  • RESEARCH MEDICAL INC overview
  • RESEARCH MEDICAL INC job
  • RESEARCH MEDICAL INC stock
  • RESEARCH MEDICAL INC ownership
  • RESEARCH MEDICAL INC CEO
  • RESEARCH MEDICAL INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

Aja Holdco, Inc.
Update: Mar 26, 2024
Solventum Corp
Update: Feb 21, 2024
WORK Medical Technology Group LTD
Update: Apr 28, 2023
MED EIBY Holding Co., Ltd
Update: Feb 25, 2023
ZYTO CORP
Update: Aug 26, 2022
ZONARE MEDICAL SYSTEMS INC
Update: Aug 26, 2022

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 1503 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 1888 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 1985 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 2530 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 1983 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 4909 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 4581 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 3921 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 4845 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by